Zhejiang Tianrui Pharmaceutical Co. Ltd., commonly referred to as Tianrui Pharma, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, primarily focusing on active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions in China and beyond, Tianrui Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, distinguished by their adherence to stringent international standards. Tianrui Pharma has achieved notable recognition in the market, positioning itself as a trusted supplier in the global pharmaceutical landscape, thanks to its robust research and development capabilities and a dedication to enhancing healthcare outcomes.
How does Zhejiang Tianrui Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zhejiang Tianrui Pharmaceutical Co. Ltd's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zhejiang Tianrui Pharmaceutical Co. Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, there is no available information on their climate commitments or initiatives aimed at reducing carbon emissions. The company may be in the early stages of developing its sustainability strategy or may not have publicly disclosed its environmental impact data. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific data or commitments from Zhejiang Tianrui Pharmaceutical Co. Ltd, it is challenging to assess their position within this evolving landscape.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhejiang Tianrui Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.